Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1990 Jun;29(6):695–701. doi: 10.1111/j.1365-2125.1990.tb03690.x

The disposition of amodiaquine in Zambians and Nigerians with malaria.

P A Winstanley 1, O Simooya 1, J M Kofi-Ekue 1, O Walker 1, L A Salako 1, G Edwards 1, M L Orme 1, A M Breckenridge 1
PMCID: PMC1380171  PMID: 2378788

Abstract

1. Oral amodiaquine (AQ) has been used to treat patients with symptomatic malaria in Zambia (n = 14) and Nigeria (n = 5). Clinical cure was obtained in all patients and no serious adverse drug reactions were seen. 2. As in healthy subjects, AQ achieved low plasma concentrations. Plasma concentration vs time profiles of desethylamodiaquine (AQm) from the present study did not differ from those obtained from healthy subjects. 3. In contrast to previous results from healthy subjects, the mean ratio of red cell (RBC): plasma AQm concentration in the present study was 0.80: 1 at the start of the study and rose in a linear manner (r = 0.873; P less than 0.01) to 3.04: 1 by the end (n = 10; P less than 0.01). The final mean value was similar to that seen in healthy subjects. 4. These data show that there are differences in the disposition of orally administered AQ between healthy subjects and patients with clinical malaria. The relevance of this observation to the frequency of adverse reactions to AQ in these two groups is not established.

Full text

PDF
695

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adelusi S. A., Dawodu A. H., Salako L. A. Kinetics of the uptake and elimination of chloroquine in children with malaria. Br J Clin Pharmacol. 1982 Oct;14(4):483–487. doi: 10.1111/j.1365-2125.1982.tb02016.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BEPLER C. R., BAIER H. N., McCRACKEN S., RENTSCHLER C. L., ROGERS F. B., LANSBURY J. A 15 month controlled study of the effects of amodiaquine (camoquin) in rheumatoid arthritis. Arthritis Rheum. 1959 Oct;2:403–413. doi: 10.1002/1529-0131(195910)2:5<403::aid-art1780020505>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  3. Booth K., Larkin K., Maddocks I. Agranulocytosis coincident with amodiaquine therapy. Br Med J. 1967 Jul 1;3(5556):32–33. doi: 10.1136/bmj.3.5556.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brandling-Bennett A. D., Oloo A. J., Watkins W. M., Boriga D. A., Kariuki D. M., Collins W. E. Chloroquine treatment of falciparum malaria in an area of Kenya of intermediate chloroquine resistance. Trans R Soc Trop Med Hyg. 1988;82(6):833–837. doi: 10.1016/0035-9203(88)90009-0. [DOI] [PubMed] [Google Scholar]
  5. Carr R. Neutropenia and prophylactic amodiaquine. Lancet. 1986 Mar 8;1(8480):556–556. doi: 10.1016/s0140-6736(86)90908-6. [DOI] [PubMed] [Google Scholar]
  6. Childs G. E., Boudreau E. F., Milhous W. K., Wimonwattratee T., Pooyindee N., Pang L., Davidson D. E., Jr A comparison of the in vitro activities of amodiaquine and desethylamodiaquine against isolates of Plasmodium falciparum. Am J Trop Med Hyg. 1989 Jan;40(1):7–11. doi: 10.4269/ajtmh.1989.40.7. [DOI] [PubMed] [Google Scholar]
  7. Churchill F. C., Patchen L. C., Campbell C. C., Schwartz I. K., Nguyen-Dinh P., Dickinson C. M. Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans. Life Sci. 1985 Jan 7;36(1):53–62. doi: 10.1016/0024-3205(85)90285-1. [DOI] [PubMed] [Google Scholar]
  8. Fitch C. D., Gonzalez Y., Chevli R. Amodiaquin accumulation by mouse erythrocytes infected with Plasmodium berghei. J Pharmacol Exp Ther. 1975 Dec;195(3):397–403. [PubMed] [Google Scholar]
  9. Fitch C. D., Yunis N. G., Chevli R., Gonzalez Y. High-affinity accumulation of chloroquine by mouse erythrocytes infected with Plasmodium berghei. J Clin Invest. 1974 Jul;54(1):24–33. doi: 10.1172/JCI107747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. GLICK L. Fatal agranulocytosis during treatment with a amodiaquine. Br Med J. 1957 Apr 20;1(5024):932–932. doi: 10.1136/bmj.1.5024.932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hatton C. S., Peto T. E., Bunch C., Pasvol G., Russell S. J., Singer C. R., Edwards G., Winstanley P. Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet. 1986 Feb 22;1(8478):411–414. doi: 10.1016/s0140-6736(86)92371-8. [DOI] [PubMed] [Google Scholar]
  12. KENNEDY A. F. Absolute neutrophil leucopenia after uncontrolled use of amodiaquine. Br Med J. 1955 Aug 20;2(4937):475–476. doi: 10.1136/bmj.2.4937.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Karbwang J., Looareesuwan S., Phillips R. E., Wattanagoon Y., Molyneux M. E., Nagachinta B., Back D. J., Warrell D. A. Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine. Br J Clin Pharmacol. 1987 Apr;23(4):477–481. doi: 10.1111/j.1365-2125.1987.tb03079.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Khaliq A. A., Fox E., Sarwar M., Strickland G. T. Amodiaquine fails to cure chloroquine resistant Plasmodium falciparum in the Punjab. Trans R Soc Trop Med Hyg. 1987;81(1):157–159. doi: 10.1016/0035-9203(87)90311-7. [DOI] [PubMed] [Google Scholar]
  15. LOVE J., FOULK R., WILLIAMS R. G. W., Jr, MITCHELL R. B. Evaluation of amodiaquin (camoquin) in the treatment of relapsing vivax malaria. Am J Med Sci. 1953 Jan;225(1):26–33. [PubMed] [Google Scholar]
  16. Mount D. L., Patchen L. C., Nguyen-Dinh P., Barber A. M., Schwartz I. K., Churchill F. C. Sensitive analysis of blood for amodiaquine and three metabolites by high-performance liquid chromatography with electrochemical detection. J Chromatogr. 1986 Dec 19;383(2):375–386. doi: 10.1016/s0378-4347(00)83483-0. [DOI] [PubMed] [Google Scholar]
  17. Neftel K. A., Woodtly W., Schmid M., Frick P. G., Fehr J. Amodiaquine induced agranulocytosis and liver damage. Br Med J (Clin Res Ed) 1986 Mar 15;292(6522):721–723. doi: 10.1136/bmj.292.6522.721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. PERRY H. O., BARTHOLOMEW L. G., HANLON D. G. Nearly fatal reaction to amodiaquine. JAMA. 1962 Feb 24;179:598–601. doi: 10.1001/jama.1962.03050080010003. [DOI] [PubMed] [Google Scholar]
  19. POMEROY H., WARREN C., MILLS D., CLARK G. M. The effect of amodiaquin (camoquin) on the course of rheumatoid arthritis. Arthritis Rheum. 1959 Oct;2:396–402. doi: 10.1002/1529-0131(195910)2:5<396::aid-art1780020504>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  20. Pussard E., Verdier F., Blayo M. C. Simultaneous determination of chloroquine, amodiaquine and their metabolites in human plasma, red blood cells, whole blood and urine by column liquid chromatography. J Chromatogr. 1986 Jan 10;374(1):111–118. doi: 10.1016/s0378-4347(00)83258-2. [DOI] [PubMed] [Google Scholar]
  21. Pussard E., Verdier F., Faurisson F., Scherrmann J. M., Le Bras J., Blayo M. C. Disposition of monodesethylamodiaquine after a single oral dose of amodiaquine and three regimens for prophylaxis against Plasmodium falciparum malaria. Eur J Clin Pharmacol. 1987;33(4):409–414. doi: 10.1007/BF00637639. [DOI] [PubMed] [Google Scholar]
  22. Rhodes E. G., Ball J., Franklin I. M. Amodiaquine induced agranulocytosis: inhibition of colony growth in bone marrow by antimalarial agents. Br Med J (Clin Res Ed) 1986 Mar 15;292(6522):717–718. doi: 10.1136/bmj.292.6522.717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Watkins W. M., Sixsmith D. G., Spencer H. C., Boriga D. A., Kariuki D. M., Kipingor T., Koech D. K. Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya. Lancet. 1984 Feb 18;1(8373):357–359. doi: 10.1016/s0140-6736(84)90410-0. [DOI] [PubMed] [Google Scholar]
  24. Watt G., Long G. W., Padre L., Alban P., Sangalang R., Ranoa C. P., Laughlin L. W. Amodiaquine less effective than chloroquine in the treatment of falciparum malaria in the Philippines. Am J Trop Med Hyg. 1987 Jan;36(1):3–8. doi: 10.4269/ajtmh.1987.36.3. [DOI] [PubMed] [Google Scholar]
  25. White N. J. Clinical pharmacokinetics of antimalarial drugs. Clin Pharmacokinet. 1985 May-Jun;10(3):187–215. doi: 10.2165/00003088-198510030-00001. [DOI] [PubMed] [Google Scholar]
  26. Winstanley P. A., Edwards G., Curtis C. G., Orme M. L., Powell G. M., Breckenridge A. M. Tissue distribution and excretion of amodiaquine in the rat. J Pharm Pharmacol. 1988 May;40(5):343–349. doi: 10.1111/j.2042-7158.1988.tb05264.x. [DOI] [PubMed] [Google Scholar]
  27. Winstanley P., Edwards G., Orme M., Breckenridge A. The disposition of amodiaquine in man after oral administration. Br J Clin Pharmacol. 1987 Jan;23(1):1–7. doi: 10.1111/j.1365-2125.1987.tb03002.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES